Related by context. All words. (Click for frequent words.) 83 Mylan Receives Approval 81 FDA Approvals 81 Generic Version 81 NDA Submission 81 Receives Orphan Drug Designation 80 Meets Primary Endpoint 80 Generic Versions 79 FDA Accepts 79 PDUFA Date 79 Generic Version Of 79 Positive Opinion 79 Patient Enrollment 79 Submits NDA 79 Psoriasis Drug 78 Fast Track Status 78 Receives Approvable Letter 78 Initiates Enrollment 77 Single Dose 77 Epilepsy Drug 77 Rheumatoid Arthritis Drug 77 Cholesterol Lowering Drug 77 Phase 2a Trial 77 Arthritis Drug 77 First Patient Treated 77 Blood Pressure Drug 77 Improves Survival 77 Granted Orphan Drug 76 Receives Positive Opinion 76 Phase IIb Trial 76 Taro Receives 76 Milestone Payment 76 FDA Clearance 76 Pivotal Phase III 76 Files IND 76 IND Filing 76 Prostate Cancer Vaccine 76 IND Application 76 Phase 2b Clinical Trial 76 Investigational Compound 76 Supplemental Biologics License Application 76 Schizophrenia Drug 76 Advanced Melanoma 76 FDA Okays 76 Investigational Treatment 76 Initiate Clinical Trial 76 Drug Candidate 75 Osteoporosis Drug 75 Patients Treated With 75 Completes Patient Enrollment 75 Announces FDA Clearance 75 Inhaled Insulin 75 FDA Clears 75 Adjuvant Treatment 75 Prolongs Survival 75 Teva Provides Update 75 Announces Tentative Approval 75 Combination Treatment 75 Testosterone Gel 75 Gout Drug 75 PRN FDA Approves 75 Migraine Drug 75 Kidney Transplant Patients 75 Pivotal Study 75 Pivotal Clinical Trial 75 Stronger Warnings 75 Phase III Clinical Trial 75 Pivotal Trial 75 Receives Orphan Drug 75 Lupus Drug 75 Long Term Efficacy 75 Pediatric Patients 75 Initiates Clinical Trial 75 Gets FDA Clearance 75 Phase III Trial 75 Completes Enrollment 74 FDA APPROVES 74 Improves Outcomes 74 Demonstrates Significant 74 Anemia Drug 74 Drug Coated Stent 74 Phase IIb Clinical Trial 74 Mg Usa 74 Myeloma Patients 74 Cholesterol Drug 74 Improved Survival 74 Cypher Sirolimus 74 Phase 2a Clinical Trial 74 First Patient Enrolled 74 Investigational Agent 74 Combination REOLYSIN R 74 liver resection surgeries 74 Phase III Trials 74 Clinical Trial Evaluating 74 Study Evaluating 74 Complicated Skin 74 Intravenous Formulation 74 Demonstrates Positive 74 Schizophrenia Treatment 74 Initiate Phase III 74 Survival Benefit 74 Novel Oral 74 BioElectronics Announces 74 Sagent Pharmaceuticals Announces 74 Clinical Trial Results 74 Blood Thinner 74 ARIXTRA R 73 Rheumatoid Arthritis Patients 73 ANDA Filing 73 Receives FDA Clearance 73 Milestone Payments 73 Phase 2b Trial 73 Tezampanel 73 Heartburn Drugs 73 Million Milestone Payment 73 Demonstrates Sustained 73 Vitrasert R 73 Treated Patients 73 Significantly Reduced 73 Adjunctive Therapy 73 Milestone Payment From 73 Fungal Infections 73 Zorbtive TM 73 Silicone Breast Implants 73 Pooled Analysis 73 Earns Milestone Payment 73 Desvenlafaxine Succinate 73 Oral Calcitonin 73 Proven Effective 73 Testosterone Patch 73 Drug Fails 73 Severe Sepsis 73 Fondaparinux 73 Develop Novel 73 Initiates Clinical 73 Unfractionated Heparin 73 Shingles Vaccine 73 Coadministration 73 OSMOPREP TM 73 FDA Approval 73 #k Clearance 73 Lung Cancer Drug 73 Osteoporosis Drugs 73 Initiates Phase III 73 Mg Uk 73 Orphan Status 73 Receives Marketing Authorization 72 Launches Generic Version 72 Serious Side Effects 72 Transdermal Patch 72 JAK Inhibitor 72 Less Invasive 72 Dose Ranging Study 72 Receives CE Marking 72 Receives Fast Track 72 Trial Evaluating 72 Treatment Naïve 72 Grants Orphan Drug 72 #mg Tablets [002] 72 Wafer polifeprosan 72 R lenalidomide 72 Weight Loss Drug 72 Glatiramer Acetate 72 Receives Complete Response 72 FDA Panel Recommends 72 Rotavirus Vaccine 72 Medoxomil 72 Achieves Primary Endpoint 72 balsalazide disodium Capsules 72 Eszopiclone 72 Prostate Cancer Patients 72 GRAS Status 72 Posaconazole 72 Demonstrates Efficacy 72 Osteoporosis Treatment 72 Significantly Improved 72 Antitumor Activity 72 SPRYCEL ® 72 Noxafil 72 Anti Tumor 72 Significantly Reduces 72 PROCTOCORT R 72 Refractory Hodgkin Lymphoma 72 Clinical Trial Data 72 VIVITROL ® 72 Low Dose 72 Hydrochlorothiazide Tablets 72 Receives Tentative Approval 72 Seasonal Influenza Vaccine 72 Improve Survival 72 Study Showed 72 Submits Supplemental 72 Treatment Reduces 72 Bivalirudin 72 Heart Stents 72 Embolic Protection 72 Breast Cancer Recurrence 72 Hemispherx flagship products 72 Immunomedics Announces 72 REPRONEX R menotropins 72 Clinical Trial Enrollment 71 STELARA TM 71 Aztreonam Lysine 71 Pivotal Phase 71 Romiplostim 71 Prophylactic Treatment 71 Anti Inflammatory Drug 71 Submits Response 71 Submits Biologics License Application 71 First Patient Dosed 71 Sodium Injection 71 Files Investigational 71 R Saizen R 71 Patent Covering 71 Adjuvant Chemotherapy 71 Bazedoxifene 71 Appears Safe 71 Ovitrelle R Serostim 71 Combo Therapy 71 Oral Fingolimod 71 Aloxi ® 71 Previously Treated 71 Preclinical Data 71 Peginterferon 71 Chemotherapy Regimen 71 Acute Attacks 71 Phase 1b Clinical Trial 71 NAVISTAR R 71 Bare Metal Stent 71 Drug Combo 71 Extended Release 71 Elderly Patients 71 Treatment Naive Patients 71 Dose Escalation 71 Pegloticase 71 Pain Relievers 71 Slow Progression 71 Overactive Bladder 71 Shows Efficacy 71 Mycophenolate Mofetil 71 Eluting Coronary Stent System 71 Investigational Drug 71 Boxed Warnings 71 Patients Suffering 71 vapreotide acetate 71 REPRONEX ® menotropins 71 Plaque Psoriasis 71 Hormone Refractory Prostate Cancer 71 Soriatane 71 Minimally Invasive Procedure 71 Effectively Treats 71 Metformin HCl 71 Shows Promise Against 71 Epilepsy Drugs 71 ACE Inhibitors 71 STERIS Corporation Announces 71 Prospective Randomized 71 Phase 2b Study 71 Shows Promising 71 Confirmatory Phase 71 Vaccine Adjuvant 71 VISICOL R 71 Neoadjuvant Chemotherapy 71 Pneumococcal Vaccine 71 PEGINTRON TM 71 Anti Clotting Drug 71 BioSante Pharmaceuticals Announces 71 Immunotherapeutic 71 Non Invasive Treatment 71 See CLINICAL PHARMACOLOGY 71 Peginterferon alfa 2b 71 Anemia Drugs 71 Recombinant Human 71 FDA Approves 71 Newly Diagnosed Patients 71 PROMUS R 71 Significantly Improves 71 Gliadel R 71 Receives Milestone Payment 71 Haemophilus b Conjugate 71 Initiates Phase II 71 Fixed Dose 71 Approvable 71 Statin Drugs 71 Endeavor Drug Eluting 71 Colorectal Cancer Patients 71 Oral Cladribine 71 Nebulized 71 External Defibrillators 71 Present Preclinical Data 71 Patients Enrolled 70 Infusion Pumps 70 Ranolazine 70 Resubmission 70 Showed Significant 70 k Clearance 70 Successfully Completes Phase 70 Asthma Treatment 70 Fewer Side Effects 70 Metastatic Melanoma 70 Demonstrate Significant 70 Regulatory Clearance 70 Vascular Grafts 70 Fluconazole 70 Cardiovascular Prosthetic Devices 70 Antimicrobial Coating 70 Nanoemulsion 70 Potentially Fatal 70 Lung Cancer Trial 70 Inhalation Aerosol 70 PROTONIX 70 Cervical Cancer Vaccine 70 ARCALYST R 70 Recommends Approval 70 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 70 Node Positive 70 Minimally Invasive Treatment 70 Obtains CE Mark 70 Drug Prevents 70 Obtains FDA 70 Multiple Myeloma Patients 70 Patients Undergoing 70 Sevelamer 70 Advanced Colorectal Cancer 70 methylnaltrexone bromide 70 Invasive Fungal Infections 70 Regenerative Cells 70 Generic Protonix 70 Serious Infections 70 Protease Inhibitor 70 Lupus Nephritis 70 Reduces Risk 70 Heart Failure Patients 70 Cancer Treatments 70 Beta Blocker 70 Calcium Acetate 70 Eluting Stent 70 SABER ™ 70 Smallpox Vaccine 70 Study Demonstrates 70 Authorized Generic 70 Renal Cell Carcinoma 70 Is Well Tolerated 70 HER2 Positive 70 Well Tolerated 70 Advanced Prostate Cancer 70 Presents Preclinical Data 70 TRANSDUR ® 70 HCl Injection 70 COLAZAL ® 70 Therapeutic Vaccine 70 Patients Receiving 70 Stem Cell Treatment 70 Orphan Designation 70 Shows Statistically Significant 70 NexMed Receives 70 Initiates Clinical Trials 70 TO AVOID PREGNANCY WHILE 70 Anti Nausea 70 Drug Shows Promise 70 Recurrent Breast Cancer 70 Presents Positive 70 Oral Mucositis 70 Vildagliptin 70 ferumoxytol Injection 70 Acne Drug 70 HCV Protease Inhibitor 70 Crofelemer budesonide foam 70 investigational pharmacologically unique 70 Clinical Study Shows 70 Enlarged Prostate 70 Release Capsules 70 injectable bulking agent 70 Interferon beta 1a 70 Aflibercept 70 Potent Antiviral Activity 70 TOPAMAX R 70 Product Designation 70 Generic Lovenox 70 Patients Treated 70 Ondansetron Injection USP 70 Drug Eluting Stent 70 Resistant Hypertension 70 sapropterin dihydrochloride 70 Thrombectomy 70 Fracture Risk 70 COLAZAL R 70 Viagra Soft Cialis Soft 70 Treatment Regimen 70 Randomized Trials 70 Cholesterol Lowering 70 TRANSDUR ™ 70 Trobalt 70 Dementia Related Psychosis 70 Bioresorbable 70 Statistically Significant 70 Metastatic Colorectal Cancer 70 Treatment Experienced 70 Topical Treatment 70 NICE Recommends 70 Capsules CII 70 Cutaneous T 70 Auto Injector 70 Efficacy Results 70 Anti Tumor Activity 70 Lung Cancer Survival 70 ODT metoclopramide HCl PEPCID 69 Humanized Anti 69 Maleate 69 TNF Blockers 69 Bepreve TM 69 Sustained Efficacy 69 rasagiline tablets 69 Drug Eluting Stent System 69 sodium benzoate prescription 69 Personalized Immunotherapy 69 Azathioprine 69 ketoconazole USP Gel 69 Hepatitis B Vaccine 69 Diet Pill 69 Data Suggest 69 markets HP Acthar 69 Novel Antibiotic 69 Renal Impairment 69 R memantine HCl 69 Certolizumab 69 Nicotine Vaccine 69 Diabetic Patients 69 Brain Metastases 69 R bendamustine hydrochloride 69 Secondary Hyperparathyroidism 69 Synthetic Peptide 69 Metabolic Disorder 69 Enrolling Patients 69 Dry Powder Inhaler 69 Submits Application 69 VIVUS Announces 69 HER2 Positive Breast Cancer 69 Drug Eluting Coronary Stent 69 markets COLAZAL 69 Desvenlafaxine 69 interferon beta 1a infertility 69 Contaminated Heparin 69 PENTASA 69 Therapeutic Competitors Companies 69 Tacrolimus 69 Bristol Myers Squibb Pravachol 69 ALVESCO ® 69 Fluticasone 69 Arthritis Drugs 69 Tumor Growth 69 corticotropin injection 69 Antidepressant Drug 69 Peginterferon Alfa 2a 69 Bare Metal Stents 69 Prostate Cancer Treatment 69 Demonstrates Potent 69 Proton Pump Inhibitors 69 TM Drug Eluting 69 abacavir sulfate lamivudine 69 Blood Pressure Reduction 69 Reduces Pain 69 Treating Chronic 69 Hypertensive Patients 69 Initiate Phase 69 Orally Disintegrating Tablets 69 Anticoagulant 69 Pharmacokinetic Study 69 Unigene nasal calcitonin 69 Diabetic Nephropathy 69 topically applied SEPA 69 Cholesterol Drugs 69 Loceryl ® 69 Glaucoma Treatment 69 Sirolimus Eluting 69 Employment Inducement Awards 69 Monotherapy 69 Bosutinib 69 Cancer Recurrence 69 Drug Coated Stents 69 Toremifene 69 Hip Fractures 69 Gel repository corticotropin injection 69 Febuxostat 69 Breast Cancer Treatment 69 Estrogen Therapy 69 Non Invasive 69 Begins Dosing 69 Postmenopausal Women 69 Contrast Agents 69 Symptom Relief 69 Vaccine Candidate 69 Lung Cancer Patients 69 FUSILEV ® 69 Dupuytren Contracture 69 Chronic Sinusitis 69 Antiplatelet 69 Microwave Ablation System 69 Naive Patients 69 Receive Milestone Payment 69 Disease Modifying 69 Treat Heart Failure 69 Expedited Review 69 Systemic Delivery 69 Demonstrated Significant 69 Augment ™ 69 Package Insert 69 Montelukast 69 Risperidone Oral Solution 69 Announce License Agreement 69 Levoleucovorin 69 Drug Eluting 69 Patient Enrolment 69 Autologous Stem Cell Transplantation 69 Premenopausal Women 69 SUPPRELIN R LA 69 Proves Effective 69 R chorionic gonadotropin 69 Erectile Dysfunction Drug 69 Androgen Deprivation Therapy 69 Sumatriptan Succinate 69 Smooth Muscle 69 Cardiovascular Monitoring 69 Tipranavir 69 Lilly Cymbalta 69 ELADUR TM 69 adenosine injection 69 Receives CE 69 Begin Clinical Trials 69 Absorbable 69 cromolyn sodium 69 Ebola Vaccine 69 ENLIGHT 69 Kuvan R 69 Controlled Trial 69 Regeneron Pharma 69 FDA Approvable Letter 69 Partial Onset Seizures 69 Voluntary Withdrawal 69 Pulmonary Arterial Hypertension 69 Diamyd Medical Diamyd 69 Weight Loss Pill 68 Inhaled Corticosteroids 68 aripiprazole Abilify 68 Increased Mortality 68 CYPHER R Sirolimus Eluting 68 Liver Damage 68 Hormone Receptor Positive 68 phenyl salicylate methylene blue 68 Demonstrates Potential 68 Pain Medications 68 Randomized Clinical Trials 68 Optimer Pharma 68 Lanthanum Carbonate 68 Clinical Evaluation 68 R bisoprolol Euthyrox 68 Oral Formulation 68 cardiometabolic diseases Glucophage 68 Drug Maker 68 Hip Implants 68 Randomized Double Blind 68 Migraine Treatment 68 Amgen Nplate 68 Moxifloxacin 68 Anticancer Drug 68 Orapred ODT 68 Lowers Risk 68 R metformin Concor 68 Sunesis Pharma 68 Hepatitis C Treatment 68 Xcytrin R 68 Shoulder Prosthesis 68 Desloratadine 68 Delayed Release 68 Contrast Agent 68 Marketing Authorisation Application 68 Intravitreal 68 Paliperidone Palmitate 68 AMMONUL R sodium phenylacetate 68 UCB Keppra 68 Artery Disease 68 Seasonal Allergic Rhinitis 68 Etravirine 68 Sustained Release 68 Diabetic Neuropathic Pain 68 Pafuramidine 68 Patent Broadly Covering 68 Efficacy Trial 68 PROCRIT R 68 REMINDER ORLive Presents 68 Acetate Rectal Suppositories 68 Genzyme Synvisc 68 ergot derivatives 68 Topical Cream 68 MetroGel 68 Myelodysplastic Syndromes 68 Camptosar ® 68 Known hypersensitivity 68 Silodosin 68 pralatrexate injection folate analogue 68 Fixed Dose Combination 68 Randomized Clinical Trial 68 Previously Untreated 68 AVASTIN 68 Begins Shipment 68 Atypical Antipsychotic 68 Slows Progression 68 GABITRIL 68 Hospital Acquired Pneumonia 68 Eculizumab 68 equine osteoarthritis marketed 68 acetonide FA 68 FDA Warns Against 68 FDA Orphan Drug 68 Lamotrigine 68 Inhalation Solution 68 HP Acthar Gel repository 68 Left Atrial Appendage 68 Effective Than 68 Hernia Repair 68 Angiox ® 68 tretinoin #.# 68 Topical Gel 68 Newly Diagnosed Multiple Myeloma 68 Novel Anti Inflammatory 68 TAXUS Element Paclitaxel Eluting 68 Adjuvanted 68 benzoic acid hyoscyamine sulfate 68 DOXIL R 68 Premature Infants 68 Raptiva R 68 Licenses Novel 68 alfa 2a 68 FDA Approves Generic 68 Vaginal Gel 68 II Clinical Trial 68 sitagliptin metformin 68 Indevus Pharma 68 Surgical Adhesive 68 Faropenem 68 Aliskiren 68 highly purified pasteurized 68 diarrhea fatigue asthenia 68 Tumor Targeting 68 Antigen Specific 68 Alpha interferons including 68 Miraculins Announces 68 GATTEX TM 68 Evoclin R 68 Cilostazol 68 Gene Variant 68 Ranexa R 68 Release Tablets 68 Versus Placebo 68 Disease Progression 68 include Alferon N 68 Antiviral Drugs 68 Cellegesic 68 Stent Placement 68 Infected Patients 68 Xolegel 68 Gonal f R 68 FDA Approves Expanded 68 Accelerated Approval 68 Benign Prostatic Hyperplasia 68 Kidney Transplant Recipients 68 SIDE EFFECTS CHEAP ONLINE 68 Alvine Pharmaceuticals 68 etanercept Enbrel 68 Fludara ® 68 nasal calcitonin product 68 Zenpep 68 Paraplatin ® 68 IV Busulfex 68 ORLive Presents 68 Pandemic Influenza Vaccine 68 TNF Tumor Necrosis Factor 68 Demonstrates Statistically Significant 68 PROMUS TM 68 Knee Osteoarthritis 68 Therapeutic Competitors Report 68 Sinus Infections 68 Interferon Alpha 68 Orphan Drug Status 68 Injection Site 68 Phase IIa Clinical Trial 68 IN PATIENTS WITH 68 Vicriviroc 68 Poniard Pharmaceuticals Announces 68 Insulin Pen 68 topical gel formulation 68 Treatment Resistant 68 Investigational Oral 68 AstraZeneca Symbicort 68 Nasdaq Deficiency Notice 68 CHEAP ONLINE PHARMACY LOW 68 Blood Glucose Meters 68 Revises FY# Outlook 68 mg Tablets 68 Combination Therapy 68 Zegerid OTC 68 erlotinib Tarceva R 68 Stent Coating 68 FOLOTYN ® 68 Announcement acc 68 Clinical Efficacy 68 COMUNICADO 68 LibiGel ® 68 Tentative Approval 68 Subgroup Analysis 68 Peripherally Inserted Central 68 Osteoarthritis Patients 68 ® lenalidomide 68 ORENCIA ® 68 Horizant ™ 68 Issues Complete Response 68 IONSYS TM 68 ® chorionic gonadotropin 68 REVLIMID R 68 Dose Finding 68 Contaminant Found 68 hydrochloride tablets 68 Cocaine Addiction 68 Soriatane R 68 Phase III Clinical Trials 68 Inhaled Nitric Oxide 68 Budesonide 68 Irinotecan 68 Topline Results 68 Betaferon R 68 Chronic Hepatitis B 68 Hydrochloride Injection 68 Monoclonal Antibody 68 Postmenopausal Osteoporosis 68 Pazopanib 68 Catapres 68 Peginterferon Alfa 2b 68 Augment TM 68 Tablets #mg [002] 68 Double Blind Placebo 68 FDA Warns 68 myelodysplastic myeloproliferative diseases 68 Reduced Risk 68 Therapy Evaluation 68 Clinically Tested 68 BUPHENYL R 68 Anticancer Activity 68 Serostim ® 68 brand ciclesonide HFA 68 dual endothelin receptor antagonist 68 Confirms Efficacy 68 Million Doses 68 adalimumab Humira 68 BAG# BAG# BAG# BAG# 68 Levels Linked 67 Antitumor 67 Allos Therapeutics Announces 67 Generic Equivalent 67 Immunosuppressant 67 Novel Compound 67 SFDA Approval 67 Tigecycline 67 TM Everolimus Eluting 67 Ovidrel 67 GTC recombinant form 67 Feraheme ® 67 Golimumab 67 Conjugate Vaccine 67 Interferon Beta 67 Therapy Reduces 67 Blood Thinning 67 Rotavirus Vaccines 67 Brentuximab Vedotin SGN 67 Bone Fracture 67 ibuprofen Injection 67 Relapsing Multiple Sclerosis 67 dasatinib Sprycel ® 67 Vimpat R 67 Liberte TM 67 DIURIL R 67 MOVIPREP R 67 Therapy Improves 67 Stent Thrombosis 67 carbamazepine phenobarbital phenytoin rifampin 67 Hsp# Inhibitor 67 Hepatitis C Genotype 67 Cinacalcet 67 Surgical Mesh 67 Corneal Transplant 67 Gonal f R follitropin 67 Antifungal 67 Plus Ribavirin 67 Potential Dangers 67 Statin Therapy 67 Mouse Model 67 Nonprescription 67 Acute Heart Failure 67 Receives SFDA Approval 67 oncolytic virus therapies 67 Liver Toxicity 67 Prolongs Life 67 ISTODAX ® 67 Improve Outcomes 67 Nilotinib 67 HepaLife TM 67 AnaSpec Introduces 67 Telithromycin 67 Renal Function 67 Soft Tissue Sarcoma 67 Stent Restenosis 67 ELADUR ™ 67 Hormone Therapy 67 Advanced Renal Cell 67 Lubiprostone 67 Sustained Reduction 67 Adjuvant Therapy 67 Tissue Engineered 67 1mg 2mg 67 Renal Cancer 67 Tyrosine Kinase Inhibitor 67 Clinical Outcome 67 RNAi Therapeutics 67 capsules USP 67 ABLYNX 67 Kuvan TM sapropterin 67 abobotulinumtoxinA 67 Bevacizumab 67 Molecular Diagnostic Test 67 RNAi Therapeutic 67 GTC recombinant human 67 candidates Azedra 67 Venous Thromboembolism 67 Drug Resistant 67 Salix Pharma 67 Vaccine Protects Against 67 NOVARTIS 67 Receives Tentative FDA 67 Pegylated Liposomal Doxorubicin 67 Blood Clotting 67 Crit Rev 67 ® tiagabine hydrochloride 67 Elagolix 67 Aldara ® 67 Commercialize Novel 67 Antipsychotic 67 C1 Inhibitor 67 Marketing Authorisation 67 Successfully Treated 67 Enrolls First 67 include Phenoptin TM 67 Pre Cancerous 67 Chronic Hepatitis C 67 Patent Issuance 67 Avian Flu Vaccine 67 Methylnaltrexone 67 Advisers Urge 67 lucinactant 67 Nitazoxanide 67 Pivotal Phase II 67 PHASE III 67 ORADUR ® 67 SYCREST 67 Surgical Sealant 67 injection USP 67 Didanosine 67 Small Molecule 67 Benazepril 67 Gene Variation 67 Atypical Antipsychotics 67 Novel Inhibitor 67 Pancreatic Adenocarcinoma 67 BioGlue R 67 Obese Patients 67 Preliminary Injunction Against 67 Severe Asthma 67 Significant Reduction 67 Relapsing Remitting Multiple Sclerosis 67 Zoloft sertraline 67 Reveals Positive 67 Vioxx Successor 67 Azacitidine 67 Ziprasidone 67 Shown Effective 67 Ondansetron Orally Disintegrating Tablets 67 Vidaza R 67 Bayer Onyx 67 Axid 67 PEGylated anti 67 Biologic Drugs 67 Melphalan 67 Nesiritide 67 Adverse Event 67 arsenic trioxide injection 67 pioglitazone HCl 67 Muscle Wasting 67 Treating Heart Failure 67 PrandiMet 67 Eltrombopag 67 Ample Supply 67 ST Elevation Myocardial 67 Gliadel ® 67 ONGLYZA TM 67 Platelet Inhibition 67 topical non steroidal 67 Epiduo 67 Gene Therapy Trial 67 Genetic Tests 67 Heart Transplant Recipients 67 Fulvestrant 67 R pioglitazone HCl 67 Oral Suspension Oral Suspension 67 Seasonal Flu Vaccine 67 ™ Everolimus Eluting 67 Phase III Pivotal 67 Drug Makers 67 Navelbine ® 67 Hycamtin ® 67 Morphine Sulfate 67 Tablet Formulation 67 Inflammatory Markers 67 Acne Medication 67 Phospholipase A2 67 Carvedilol 67 PharmaVitae Profile 67 Device Maker 67 Civacir 67 Saizen ® 67 memantine HCl 67 Bone Graft 67 FASLODEX 67 Genetic Mutation 67 Viagra Cialis Accutane 67 Fast Track Designation 67 Alair System 67 Vascular Closure Device 67 Levaquin levofloxacin 67 oropharyngeal candidiasis OPC 67 Increases Risk 67 Enteral Feed Devices 67 BARACLUDE R 67 Patent Issued 67 Roche Boniva 67 Fast Track designations 67 Aloxi R 67 Nuvelo Announces 67 Gene Variants 67 COPEGUS R 67 Factor Xa Inhibitor 67 Oral Solution 67 Blood Clot Risk 67 Misonix Announces 67 NEUPOGEN R 67 Palonosetron 67 lansoprazole Prevacid 67 Reduces Mortality 67 Full Prescribing Information 67 Divalproex Sodium 67 inhalation aerosol 67 Kidney Function 67 Post Operative 67 Lung Cancer Detection 67 Neulasta R 67 Predict Risk 67 Kepivance 67 R famotidine 67 Bucindolol Based 67 Controlled Study 67 Unmet Medical 67 Fluticasone Propionate 67 Carotid Artery Stenting 67 fentanyl buccal tablet 66 Delayed Release Tablets 66 Generic Levitra Vardenafil 66 Glufosfamide 66 Cognitive Impairment 66 Reports Preclinical Data 66 THERMOCOOL R 66 Efficacious 66 Telaprevir VX 66 Sign Licensing Agreement 66 Deep Venous Thrombosis 66 Issued Patent 66 novel emulsion formulation 66 Multaq dronedarone 66 include Healive 66 Hydrochlorothiazide 66 Initiates Phase 2b 66 Qvar 66 risedronate sodium tablets 66 metformin HCl 66 Orthostatic Hypotension 66 CE Marked 66 Bendamustine 66 Diabetic Neuropathy 66 HYVISC ® treatment 66 Recurrent Glioblastoma 66 Swine Flu Vaccines 66 Phase Ib Clinical Trial 66 JAK2 Inhibitor 66 Endologix Powerlink System